← Back to Search

Race: Non-Hispanic African American for Prostate Cancer (PCW Trial)

N/A
Waitlist Available
Led By Joanne Sandberg
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 3 months after treatment completion
Awards & highlights

Summary

The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.

Eligible Conditions
  • Prostate Cancer
  • Prostate Adenocarcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 3 months after treatment completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 3 months after treatment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in work ability measured by Global Work Ability
Secondary outcome measures
Difference between preferred and actual length of leave
Trajectory of change in work ability at 3 months measured by Global Work Ability
Trajectory of change in work ability at 3 months measured by Work Limitations Questionnaire (WLQ)
+4 more
Other outcome measures
Effect of race and income on treatment-related function, work environment, and type of treatment

Trial Design

4Treatment groups
Experimental Treatment
Group I: Race: Non-Hispanic WhiteExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group II: Race: Non-Hispanic African AmericanExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group III: Income: Lower IncomeExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group IV: Income: Higher IncomeExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,452 Total Patients Enrolled
21 Trials studying Prostate Cancer
1,769 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
41,002,634 Total Patients Enrolled
567 Trials studying Prostate Cancer
529,809 Patients Enrolled for Prostate Cancer
Joanne SandbergPrincipal InvestigatorWake Forest University Health Sciences
~12 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top